disease,molecule,phase,sponsor
Oncology,Pembrolizumab,Phase III,Merck
Oncology,Nivolumab,Phase III,Bristol Myers Squibb
Oncology,Pembrolizumab,Phase II,Merck
Oncology,Atezolizumab,Phase II,Roche
Cardiology,Atorvastatin,Phase IV,Pfizer
Oncology,Dostarlimab,Phase I,GSK
Neurology,Aducanumab,Phase III,Biogen
Oncology,Pembrolizumab,Phase I,Merck
